Warmuth Markus
SEC insider (Form 3/4/5 filer). CIK 0001855643. President & CEO at Monte Rosa Therapeutics, Inc. (GLUE). 12 reported Form 4/5 transactions since Sep 2024; latest on Jul 16, 2026. Located in BOSTON, MA.
Companies Warmuth Markus has filed insider reports for
- Monte Rosa Therapeutics, Inc. (GLUE): Director, Officer, President & CEO
Warmuth Markus
CIK: 0001855643
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Monte Rosa Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Jul 16, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect9.5K shares at avg. $23.18$220K - Jun 1, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect5K shares at avg. $19.41$97K - Jun 1, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect468 shares at avg. $19.73$9K - May 1, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect5.5K shares at avg. $18.92$103K - Apr 14, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect8K shares at avg. $17.64$141K - Mar 2, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect5.5K shares at avg. $17.92$98K - Jan 7, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect1.5K shares at avg. $23.88$35K - Jan 7, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect3.7K shares at avg. $23.24$86K - Jan 7, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect309 shares at avg. $24.57$8K - Jan 5, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect10.1K shares at avg. $15.17$154K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 16, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Sale | 9,500 | $23.18 | $220,219 | Direct |
| Jun 1, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Sale | 4,998 | $19.41 | $97,021 | Direct |
| Jun 1, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Sale | 468 | $19.73 | $9,232 | Direct |
| May 1, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Sale | 5,467 | $18.92 | $103,447 | Direct |
| Apr 14, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Sale | 8,000 | $17.64 | $141,125 | Direct |
| Mar 2, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Sale | 5,466 | $17.92 | $97,974 | Direct |
| Jan 7, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Sale | 1,450 | $23.88 | $34,620 | Direct |
| Jan 7, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Sale | 3,707 | $23.24 | $86,159 | Direct |
| Jan 7, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Sale | 309 | $24.57 | $7,593 | Direct |
| Jan 5, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Sale | 10,135 | $15.17 | $153,748 | Direct |
1-10 of 12 transactions